|
1
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
de Vita F, Di Martino N, Fabozzi A,
Laterza MM, Ventriglia J, Savastano B, Petrillo A, Gambardella V,
Sforza V, Marano L, et al: Clinical management of advanced gastric
cancer: The role of new molecular drugs. World J Gastroenterol.
20:14537–14558. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Kim MY, Cho JH and Cho JY: Ever-changing
endoscopic treatment for early gastric cancer:
Yesterday-today-tomorrow. World J Gastroenterol. 20:13273–13283.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Tsukada J, Yoshida Y, Kominato Y and Auron
PE: The CCAAT/enhancer (C/EBP) family of basic-leucine zipper
(bZIP) transcription factors is a multifaceted highly-regulated
system for gene regulation. Cytokine. 54:6–19. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kheolamai P and Dickson AJ: Liver-enriched
transcription factors are critical for the expression of hepatocyte
marker genes in mES-derived hepatocyte-lineage cells. BMC Mol Biol.
10:352009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Tomizawa M, Garfield S, Factor V and
Xanthopoulos KG: Hepatocytes deficient in CCAAT/enhancer binding
protein alpha (C/EBP alpha) exhibit both hepatocyte and biliary
epithelial cell character. Biochem Biophys Res Commun. 249:1–5.
1998. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Yamasaki H, Sada A, Iwata T, Niwa T,
Tomizawa M, Xanthopoulos KG, Koike T and Shiojiri N: Suppression of
C/EBPalpha expression in periportal hepatoblasts may stimulate
biliary cell differentiation through increased Hnf6 and Hnf1b
expression. Development. 133:4233–4243. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Akira S, Isshiki H, Sugita T, Tanabe O,
Kinoshita S, Nishio Y, Nakajima T, Hirano T and Kishimoto T: A
nuclear factor for IL-6 expression (NF-IL6) is a member of a C/EBP
family. EMBO J. 9:1897–1906. 1990.PubMed/NCBI
|
|
9
|
Tomizawa M, Horie H, Yamamoto H, Matsunaga
T, Sasaki F, Hashizume K, Hiyama E, Kaneko M, Suita S, Ando H, et
al: Reciprocal expression of CCAAT/enhancer binding proteins α and
β in hepatoblastomas and its prognostic significance. Oncol Rep.
17:341–344. 2007.PubMed/NCBI
|
|
10
|
Balamurugan K and Sterneck E: The many
faces of C/EBPδ and their relevance for inflammation and cancer.
Int J Biol Sci. 9:917–933. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Yates JL, Warren N and Sugden B: Stable
replication of plasmids derived from Epstein-Barr virus in various
mammalian cells. Nature. 313:812–815. 1985. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Antonson P and Xanthopoulos KG: Molecular
cloning, sequence, and expression patterns of the human gene
encoding CCAAT/enhancer binding protein alpha (C/EBP alpha).
Biochem Biophys Res Commun. 215:106–113. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Davies B and Fried M: The L19 ribosomal
protein gene (RPL19): Gene organization, chromosomal mapping, and
novel promoter region. Genomics. 25:372–380. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Tam S, Clavijo A, Engelhard EK and
Thurmond MC: Fluorescence-based multiplex real-time RT-PCR arrays
for the detection and serotype determination of foot-and-mouth
disease virus. J Virol Methods. 161:183–191. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Regalo G, Resende C, Wen X, Gomes B,
Durães C, Seruca R, Carneiro F and Machado JC: C/EBP alpha
expression is associated with homeostasis of the gastric epithelium
and with gastric carcinogenesis. Lab Invest. 90:1132–1139. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Tomizawa M, Wang YQ, Ebara M, Saisho H,
Watanabe K, Nakagawara A and Tagawa M: Decreased expression of the
CCAAT/enhancer binding protein α gene involved in hepatocyte
proliferation in human hepatocellular carcinomas. Int J Mol Med.
9:597–600. 2002.PubMed/NCBI
|
|
17
|
Tomizawa M, Watanabe K, Saisho H,
Nakagawara A and Tagawa M: Down-regulated expression of the
CCAAT/enhancer binding protein alpha and beta genes in human
hepatocellular carcinoma: A possible prognostic marker. Anticancer
Res. 23:351–354. 2003.PubMed/NCBI
|
|
18
|
Shi DB, Wang YW, Xing AY, Gao JW, Zhang H,
Guo XY and Gao P: C/EBPα-induced miR-100 expression suppresses
tumor metastasis and growth by targeting ZBTB7A in gastric cancer.
Cancer Lett. 369:376–385. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Chen JJ, Huang WC and Chen CC:
Transcriptional regulation of cyclooxygenase-2 in response to
proteasome inhibitors involves reactive oxygen species-mediated
signaling pathway and recruitment of CCAAT/enhancer-binding protein
delta and CREB-binding protein. Mol Biol Cell. 16:5579–5591. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Li CF, Tsai HH, Ko CY, Pan YC, Yen CJ, Lai
HY, Yuh CH, Wu WC and Wang JM: HMDB and 5-AzadC combination
reverses tumor suppressor CCAAT/enhancer-binding protein delta to
strengthen the death of liver cancer cells. Mol Cancer Ther.
14:2623–2633. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Regalo G, Canedo P, Suriano G, Resende C,
Campos ML, Oliveira MJ, Figueiredo C, Rodrigues-Pereira P, Blin N,
Seruca R, et al: C/EBPbeta is over-expressed in gastric
carcinogenesis and is associated with COX-2 expression. J Pathol.
210:398–404. 2006. View Article : Google Scholar : PubMed/NCBI
|
